evobrutinib
R&D/ Views & Analysis/ Views and analysis
Tackling the remaining challenges of multiple sclerosis
George Underwood
evobrutinib, Merck KGaA, multiple sclerosis
0 Comment
X
Tackling the remaining challenges of multiple sclerosis
https://pharmaphorum.com/r-d/views-analysis-r-d/tackling-the-remaining-challenges-of-multiple-sclerosis/